Latest Insider Transactions at Workiva Inc (WK)
This section provides a real-time view of insider transactions for Workiva Inc (WK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WORKIVA INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WORKIVA INC's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 29
2025
|
Astha Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+50.0%
|
-
|
May 29
2025
|
Michael M Crow Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+7.79%
|
-
|
May 29
2025
|
Suku V. Radia Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+19.58%
|
-
|
May 29
2025
|
David S. Mulcahy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+1.31%
|
-
|
May 29
2025
|
Robert H Herz Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+7.94%
|
-
|
May 29
2025
|
Martin J. Vanderploeg Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,218
+1.0%
|
-
|
May 23
2025
|
Jill Klindt EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
7,773
-6.74%
|
$520,791
$67.1 P/Share
|
May 09
2025
|
Jill Klindt EVP, CFO & Treasurer |
SELL
Bona fide gift
|
Direct |
3,700
-3.11%
|
-
|
May 05
2025
|
Martin J. Vanderploeg Director |
BUY
Bona fide gift
|
Indirect |
84,210
+16.07%
|
-
|
May 05
2025
|
Martin J. Vanderploeg Director |
SELL
Bona fide gift
|
Direct |
84,210
-21.12%
|
-
|
Apr 15
2025
|
Martin J. Vanderploeg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
84,210
+17.44%
|
$1,178,940
$14.74 P/Share
|
Apr 03
2025
|
Julie Iskow President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,564
-2.06%
|
$521,916
$69.25 P/Share
|
Mar 14
2025
|
Robert H Herz Director |
SELL
Open market or private sale
|
Indirect |
1,500
-3.92%
|
$132,000
$88.66 P/Share
|
Mar 14
2025
|
Robert H Herz Director |
SELL
Open market or private sale
|
Direct |
1,000
-2.85%
|
$88,000
$88.7 P/Share
|
Mar 13
2025
|
Michael D. Hawkins EVP, Sales |
SELL
Open market or private sale
|
Direct |
8,992
-14.67%
|
$764,320
$85.91 P/Share
|
Mar 07
2025
|
Jill Klindt EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
5,593
-4.49%
|
$475,405
$85.04 P/Share
|
Mar 07
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
SELL
Open market or private sale
|
Direct |
4,115
-3.82%
|
$349,775
$85.72 P/Share
|
Mar 07
2025
|
Michael D. Hawkins EVP, Sales |
SELL
Open market or private sale
|
Direct |
10,421
-14.53%
|
$885,785
$85.43 P/Share
|
Mar 01
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-0.73%
|
$68,382
$87.52 P/Share
|
Mar 01
2025
|
Julie Iskow President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,539
-0.88%
|
$568,893
$87.52 P/Share
|
Mar 01
2025
|
Julie Iskow President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,812
+1.01%
|
-
|
Feb 20
2025
|
Michael D. Hawkins EVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
5,852
-7.54%
|
$503,272
$86.55 P/Share
|
Feb 20
2025
|
Michael D. Hawkins EVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
11,520
+4.87%
|
-
|
Feb 20
2025
|
Jill Klindt EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,591
-5.02%
|
$566,826
$86.55 P/Share
|
Feb 20
2025
|
Jill Klindt EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
15,273
+3.83%
|
-
|
Feb 20
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,364
-5.54%
|
$547,304
$86.55 P/Share
|
Feb 20
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
12,464
+3.57%
|
-
|
Feb 20
2025
|
Julie Iskow President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,918
-4.37%
|
$1,454,948
$86.55 P/Share
|
Feb 20
2025
|
Julie Iskow President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
31,413
+2.66%
|
-
|
Feb 20
2025
|
Martin J. Vanderploeg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
438
-0.14%
|
$37,668
$86.55 P/Share
|
Feb 20
2025
|
Martin J. Vanderploeg Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,828
+0.89%
|
-
|
Feb 03
2025
|
Junko Swain SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,396
+16.84%
|
$523,412
$97.29 P/Share
|
Feb 03
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
26,621
+20.65%
|
$2,582,237
$97.29 P/Share
|
Feb 03
2025
|
Michael D. Hawkins EVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
28,780
+30.35%
|
$2,791,660
$97.29 P/Share
|
Feb 03
2025
|
Julie Iskow President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,730
+22.06%
|
$9,770,810
$97.29 P/Share
|
Feb 03
2025
|
Jill Klindt EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
32,018
+21.64%
|
$3,105,746
$97.29 P/Share
|
Feb 01
2025
|
Junko Swain SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
606
-2.77%
|
$59,388
$98.22 P/Share
|
Feb 01
2025
|
Brandon Ziegler EVP, CLO, CAO & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,612
-13.3%
|
$1,137,976
$98.22 P/Share
|
Feb 01
2025
|
Michael D. Hawkins EVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
12,616
-25.29%
|
$1,236,368
$98.22 P/Share
|
Feb 01
2025
|
Julie Iskow President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,596
-10.08%
|
$2,802,408
$98.22 P/Share
|
Feb 01
2025
|
Jill Klindt EVP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,314
-12.79%
|
$1,206,772
$98.22 P/Share
|
Feb 01
2025
|
Martin J. Vanderploeg Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,886
-0.92%
|
$282,828
$98.22 P/Share
|
Jan 10
2025
|
Martin J. Vanderploeg Director |
BUY
Bona fide gift
|
Indirect |
9,806
+2.68%
|
-
|
Jan 10
2025
|
Martin J. Vanderploeg Director |
SELL
Bona fide gift
|
Direct |
9,806
-3.02%
|
-
|
Nov 27
2024
|
David S. Mulcahy Director |
SELL
Bona fide gift
|
Direct |
5,000
-2.05%
|
-
|
Nov 11
2024
|
Suku V. Radia Director |
SELL
Open market or private sale
|
Indirect |
25,678
-47.7%
|
$2,439,410
$95.0 P/Share
|
Nov 11
2024
|
Robert H Herz Director |
SELL
Open market or private sale
|
Indirect |
4,800
-11.13%
|
$451,200
$94.77 P/Share
|
Nov 11
2024
|
Robert H Herz Director |
SELL
Open market or private sale
|
Direct |
3,177
-8.3%
|
$298,638
$94.69 P/Share
|
Sep 13
2024
|
Michael D. Hawkins EVP, Sales |
SELL
Open market or private sale
|
Direct |
2,761
-5.24%
|
$204,314
$74.6 P/Share
|
Sep 11
2024
|
Martin J. Vanderploeg Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+0.58%
|
$280,000
$70.33 P/Share
|